Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132351) titled 'Study on the Mechanism of Methionine Promoting Microvascular Invasion of Hepatocellular Carcinoma Cell Subpopulations (STMN1+/EZH2+) through Metabolic-Epigenetic Reprogramming' on Sept. 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking Union Medical College Hospital
Condition:
HCC accompanied by MVI confirmed by postoperative pathology.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-16
Target Sample Size: MVI group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341642
Publis...